v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | NCT04357457 |
Full text link
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
|
First author
Last imported at : Oct. 19, 2021, 4 p.m. Source : ClinicalTrials.gov |
|
Contact
Last imported at : Oct. 19, 2021, 4 p.m. Source : ClinicalTrials.gov |
yonathman@gmail.com |
Registration date
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2020-04-22 |
Recruitment status
Last imported at : May 6, 2022, 5 a.m. Source : ClinicalTrials.gov |
Completed |
Study design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
RCT |
Allocation
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Randomized |
Design
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Parallel |
Masking
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Blind label |
Center
Last imported at : March 15, 2023, 4 a.m. Source : ClinicalTrials.gov |
single-center |
Study aim
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Treatment |
Inclusion criteria
Last imported at : May 13, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
inclusion criteria: - adults patients aged 80 years or less - covid-19 diagnosis defined as either positive rt-pcr for sars-cov-2 or covid-19 compatible or typical chest ct pattern or positive serology for covid-19 antibodies - hypoxemic acute respiratory failure with the following criteria: oxygen saturation level of 92% or less, as measured by pulsed oximetry (spo2) under oxygen therapy with an oxygen rate of 6l/min or more. - hospital admission for covid-19 within 14 days - patients affiliated |
Exclusion criteria
Last imported at : Oct. 19, 2021, 4 p.m. Source : ClinicalTrials.gov |
- hypersensitivity to the active substance or to any of the excipients - pregnancy or breastfeeding woman - known hepatic failure (pt <50%, factor v < 50%) - last known plasma total bilirubin > 21 μmol/l - lactate level > 4 mmol/l - alt and ast levels greater than 3 times the upper limit - pulmonary hypertension (paps ≥37 mmhg and/or vmaxit ≥ 2,9 m/s) or right ventricular dysfunction - history of pulmonary embolism - diagnosis of pulmonary embolism during the current hospitalization or on-going anticoagulant therapy at curative dose for thromboembolism when hospitalized - paco2 > 45 mmhg - exacerbation of asthma or chronic respiratory failure - cardiogenic pulmonary oedema - systolic blood pressure of 90 mmhg or less, or use of vasopressors - urgent need for endotracheal intubation at the discretion of the treating physician - do-not-intubate order or estimated life expectancy less than 6 months - participation in another interventional research |
Number of arms
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
2 |
Funding
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Assistance Publique - Hôpitaux de Paris |
Inclusion age min
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
18 |
Inclusion age max
Last imported at : March 25, 2021, 12:31 a.m. Source : ClinicalTrials.gov |
75 |
Countries
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
France |
Type of patients
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Severe/critical disease at enrollment |
Severity scale
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
7: Severe/critical disease at enrollment |
Total sample size
Last imported at : Oct. 19, 2021, 4 p.m. Source : ClinicalTrials.gov |
181 |
primary outcome
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
Rate of endotracheal intubation |
Notes
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
None |
Phase
Last imported at : Feb. 25, 2021, 7:58 p.m. Source : ClinicalTrials.gov |
Phase 3 |
Arms
Last imported at : Oct. 26, 2020, 11:31 p.m. Source : ClinicalTrials.gov |
[{"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": 68, "treatment_name": "Almitrine", "treatment_type": "Respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}] |